Heranba Industries Limited · NSE:HERANBA
Heranba Industries — Investor Presentation (November 2023)
10 slides from Heranba Industries's investor presentation, Nov 8, 2023
Slide 1: Exchange filing cover letter: Investor Presentation on Acquisition
November 08, 2023 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Plot no. C/l, G Block, Mumbai- 400001, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051. Scrip Code: 543266 Symbol: HERANBA Dear Sir/Madam, Sub: Investor Pres
Slide 2: Contract Research Organization (CRO): An Overview
Contract Research Organization (CRO) An Overview BSE: 543266 | NSE: HERANBA | ISIN: INE694N01015 www.heranba.co.in
Slide 3: Safe Harbor
Safe This presentation and the accompanying slides (the “Presentation”), which have been prepared by Heranba Industries Harbor Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any se
Slide 4: Heranba at a Glance
Heranba at a Glance 60+ 4 65+ 950+ Revenue from Institutional Manufacturing Countries Employees customers** Facilities Presence (as of FY23) (as of FY23) 8500+ 41% ~20% Dealers Revenue from Revenue from 14.4% Exports as % of sales Top 10 customers ROE# across India (as of FY23) (as of FY23) (as of F
Slide 5: New R & D Centre - Tarapur
New R & D Centre - Tarapur Objective To Set-up a world class R&D Centre to attract, collaborate and partner with leading multinational companies in agrochemical, pharmaceutical, biopharmaceutical, speciality chemical space which work in their niche area starting from discovery of new chemical entiti
Slide 6: Planning
Planning Apart from existing 30 highly qualified scientists working in current set-up which would be moving to new R&D center, Heranba has budgeted 60 scientists in the first phase which would cater to Synthetic Chemistry, Analytical Research, Formulation Development and Pilot plant Services. With t
Slide 7: Planning
Planning Our scientists will operate in modern laboratories and supported with well-defined processes to solve multi step complex synthetic challenges. Supported by analytical scientists providing reliable analytical data, this team will adopt quality documentation procedures to protect customer IP
Slide 8: Capex Plan Phase-1
Capex Plan Phase-1 The company has budgeted ₹50 crore in the first phase to revamp the existing setup and develop the R&D center to facilitate the business expansion into new markets by way of new and innovative strategies to integrate concepts and commercialization by providing suitable cost effect
Slide 9: Capex Plan Phase-2
Capex Plan Phase-2 In the 2nd phase, Heranba will explore setting up of a GLP facility and expansion of manufacturing capabilities. The composite team of scientists will be responsible to deliver synthesis and analytical solutions including method development and validation studies, product stabilit
Slide 10: Thank You
Corporate Office Investor Relations Contacts: Heranba Industries Ltd. Abdul Latif 2nd Floor, A Wing, Fortune Avirahi, Heranba Industries Ltd. Tel No.: +91 22 2898 7912 Jain Derasar Lane, Near Moksh Plaza, Email: compliance@heranba.com Borivali (West), Mumbai – 400 092, India Tel : 91-22-2898 7912/14
Heranba Industries — Investor Presentation (November 2023) on 6ix